NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cross Border Impact Ventures

Cross Border Impact Ventures

Toronto, Ontariocrossborder.ventures

Overview

Cross-Border Impact Ventures is an impact venture capital firm on a mission to revolutionize venture investing in health technology. They invest in world class, early-growth stage health technology companies commercializing medical devices, diagnostics, therapeutics, and digital health innovations that benefit women, children and adolescents. The firm targets venture returns for its investors and empower its portfolio companies to reach beyond their primary markets in the United States and Europe to reach more vulnerable populations in emerging markets.

Year Founded

2019

Portfolio Companies

13

Investments

Cross Border Impact Ventures investments
CompanyDateStageLead
TidalSenseJul 2026Early FundingCo-investor
BactolifeJan 2026Series BLead
Pendulum TherapeuticsFeb 2025SeedCo-investor
Oxford Cancer AnalyticsJan 2025Series ALead
OncoLensOct 2024Series BLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersToronto, Ontario
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.